ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Moffitt, Ohio State Form Network, Invite Major Cancer Centers to Join

May 30, 2014

Prostatectomy Improves Outcome In Some Men

August 29, 2008

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

DCT Announces Neutron Therapy RFP Available

January 19, 1979